Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

The Effect of Meningococcal Vaccines on New Generation of Systemic Inflammatory Markers in Children

Version 1 : Received: 3 June 2024 / Approved: 3 June 2024 / Online: 4 June 2024 (12:34:14 CEST)

How to cite: Okuyan, O.; Dumur, S.; Elgormus, Y.; Sayılı, U.; Uzun, H. The Effect of Meningococcal Vaccines on New Generation of Systemic Inflammatory Markers in Children. Preprints 2024, 2024060135. https://doi.org/10.20944/preprints202406.0135.v1 Okuyan, O.; Dumur, S.; Elgormus, Y.; Sayılı, U.; Uzun, H. The Effect of Meningococcal Vaccines on New Generation of Systemic Inflammatory Markers in Children. Preprints 2024, 2024060135. https://doi.org/10.20944/preprints202406.0135.v1

Abstract

Objective: Meningococcal meningitis (MM) is an acute, severe respiratory infectious disease caused by Neisseria meningitidis and remains an important cause of morbidity/mortality in children. Immunization with meningococcal vaccine (MV) is the most effective measure to control and prevent the transmission of MM. In this study, in order to support the appropriate use of various MVs in the prevention of MM, the effects of MVs, especially single-dose and inter-booster administered, on inflammatory parameters in

Keywords

Meningococcal vaccine, Nimenrix, Bexsero, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic inflammation response index, systemic immune inflammation index.

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.